• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

间充质干细胞在胰岛移植中的免疫调节作用。

Immunomodulation effect of mesenchymal stem cells in islet transplantation.

机构信息

College of Pharmacy, Yeungnam University, Gyeongsan, Gyeongbuk 38541, Republic of Korea.

Department of Biomedical Chemistry, College of Biomedical & Health Science, Konkuk University, Chungju 27478, Republic of Korea.

出版信息

Biomed Pharmacother. 2021 Oct;142:112042. doi: 10.1016/j.biopha.2021.112042. Epub 2021 Aug 14.

DOI:10.1016/j.biopha.2021.112042
PMID:34403963
Abstract

Mesenchymal stem cells (MSCs) therapy has brought a great enthusiasm to the treatment of various immune disorders, tissue regeneration and transplantation therapy. MSCs are being extensively investigated for their immunomodulatory actions. MSCs can deliver immunomodulatory signals to inhibit allogeneic T cell immune responses by downregulating pro-inflammatory cytokines and increasing regulatory cytokines and growth factors. Islet transplantation is a therapeutic alternative to the insulin therapy for the treatment of type 1 diabetes mellitus (T1DM). However, the acute loss of islets due to the lack of vasculature and hypoxic milieu in the immediate post-transplantation period may lead to treatment failure. Moreover, despite the use of potent immunosuppressive drugs, graft failure persists because of immunological rejection. Many in vitro and in vivo researches have demonstrated the multipotency of MSCs as a mediator of immunomodulation and a great approach for enhancement of islet engraftment. MSCs can interact with immune cells of the innate and adaptive immune systems via direct cell-cell contact or through secretomes containing numerous soluble growth and immunomodulatory factors or mitochondrial transfer. This review highlights the interactions between MSCs and different immune cells to mediate immunomodulatory functions along with the importance of MSCs therapy for the successful islet transplantation.

摘要

间充质干细胞 (MSCs) 治疗为各种免疫紊乱、组织再生和移植治疗带来了巨大的热情。MSCs 的免疫调节作用正在被广泛研究。MSCs 可以通过下调促炎细胞因子和增加调节性细胞因子和生长因子来传递免疫调节信号,抑制同种异体 T 细胞免疫反应。胰岛移植是治疗 1 型糖尿病 (T1DM) 的胰岛素治疗的一种替代疗法。然而,由于移植后即刻血管缺乏和缺氧环境,胰岛会急性丢失,这可能导致治疗失败。此外,尽管使用了强效的免疫抑制剂,由于免疫排斥,移植物仍然会衰竭。许多体外和体内研究表明,MSCs 作为免疫调节的介质和增强胰岛移植的一种方法具有多能性。MSCs 可以通过直接细胞-细胞接触或通过包含许多可溶性生长和免疫调节因子或线粒体转移的分泌组与先天和适应性免疫系统的免疫细胞相互作用。本综述强调了 MSCs 与不同免疫细胞之间的相互作用,以介导免疫调节功能,以及 MSCs 治疗在成功胰岛移植中的重要性。

相似文献

1
Immunomodulation effect of mesenchymal stem cells in islet transplantation.间充质干细胞在胰岛移植中的免疫调节作用。
Biomed Pharmacother. 2021 Oct;142:112042. doi: 10.1016/j.biopha.2021.112042. Epub 2021 Aug 14.
2
Immunomodulatory and protective effects of adipose tissue-derived mesenchymal stem cells in an allograft islet composite transplantation for experimental autoimmune type 1 diabetes.脂肪组织来源的间充质干细胞在实验性自身免疫性1型糖尿病同种异体胰岛复合移植中的免疫调节和保护作用
Immunol Lett. 2017 Aug;188:21-31. doi: 10.1016/j.imlet.2017.05.006. Epub 2017 May 12.
3
Interleukin (IL)-10 induced by CD11b(+) cells and IL-10-activated regulatory T cells play a role in immune modulation of mesenchymal stem cells in rat islet allografts.CD11b(+) 细胞诱导的白细胞介素 (IL)-10 和 IL-10 激活的调节性 T 细胞在大鼠胰岛同种异体移植物中调节间充质干细胞的免疫中发挥作用。
Mol Med. 2011;17(7-8):697-708. doi: 10.2119/molmed.2010.00098. Epub 2011 Feb 25.
4
The Unique Immunomodulatory Properties of MSC-Derived Exosomes in Organ Transplantation.间充质干细胞衍生外泌体在器官移植中的独特免疫调节特性
Front Immunol. 2021 Apr 6;12:659621. doi: 10.3389/fimmu.2021.659621. eCollection 2021.
5
Reduction of marginal mass required for successful islet transplantation in a diabetic rat model using adipose tissue-derived mesenchymal stromal cells.利用脂肪组织来源的间充质基质细胞减少糖尿病大鼠模型中胰岛移植成功所需的边缘质量。
Cytotherapy. 2018 Sep;20(9):1124-1142. doi: 10.1016/j.jcyt.2018.06.001. Epub 2018 Jul 29.
6
The Immunomodulatory Properties of the Human Amnion-Derived Mesenchymal Stromal/Stem Cells Are Induced by INF-γ Produced by Activated Lymphomonocytes and Are Mediated by Cell-To-Cell Contact and Soluble Factors.人羊膜来源间充质基质/干细胞的免疫调节特性是由激活的淋巴母细胞产生的 INF-γ诱导的,其通过细胞间接触和可溶性因子介导。
Front Immunol. 2020 Feb 12;11:54. doi: 10.3389/fimmu.2020.00054. eCollection 2020.
7
Mesenchymal stem cells prevent acute rejection and prolong graft function in pancreatic islet transplantation.间充质干细胞可预防胰岛移植的急性排斥反应并延长移植物功能。
Diabetes Technol Ther. 2010 Jun;12(6):435-46. doi: 10.1089/dia.2009.0154.
8
Utility of co-transplanting mesenchymal stem cells in islet transplantation.同种异体间充质干细胞共移植在胰岛移植中的应用。
World J Gastroenterol. 2011 Dec 21;17(47):5150-5. doi: 10.3748/wjg.v17.i47.5150.
9
Immunomodulatory mechanisms of mesenchymal stem cells and their therapeutic applications.间充质干细胞的免疫调节机制及其治疗应用。
Cell Immunol. 2018 Apr;326:68-76. doi: 10.1016/j.cellimm.2017.08.009. Epub 2017 Sep 11.
10
Potential role of mesenchymal stromal cells in pancreatic islet transplantation.间充质基质细胞在胰岛移植中的潜在作用。
Transplant Rev (Orlando). 2013 Jan;27(1):21-9. doi: 10.1016/j.trre.2012.11.003. Epub 2013 Jan 3.

引用本文的文献

1
Mesenchymal stem cell-based therapy for peripheral nerve injuries: A promise or reality?基于间充质干细胞的外周神经损伤治疗:是希望还是现实?
World J Stem Cells. 2025 Jun 26;17(6):107833. doi: 10.4252/wjsc.v17.i6.107833.
2
Tissue Engineering and Regenerative Medicine: Perspectives and Challenges.组织工程与再生医学:前景与挑战
MedComm (2020). 2025 Apr 24;6(5):e70192. doi: 10.1002/mco2.70192. eCollection 2025 May.
3
Unleashing the Potential: Exploring the Application and Mechanism of Mesenchymal Stem Cells in Autoimmune Diseases.
释放潜能:探索间充质干细胞在自身免疫性疾病中的应用及机制
Stem Cells Int. 2025 Apr 15;2025:9440377. doi: 10.1155/sci/9440377. eCollection 2025.
4
Potentials of bone marrow cells-derived from naïve or diabetic mice in autoimmune type 1 diabetes: immunomodulatory, anti-inflammatory, anti hyperglycemic, and antioxidative.骨髓细胞源自幼稚或糖尿病小鼠在自身免疫 1 型糖尿病中的作用:免疫调节、抗炎、降血糖和抗氧化。
Endocrine. 2024 Dec;86(3):959-979. doi: 10.1007/s12020-024-03929-7. Epub 2024 Jul 17.
5
Advancements in innate immune regulation strategies in islet transplantation.胰岛移植中固有免疫调控策略的进展。
Front Immunol. 2024 Jan 15;14:1341314. doi: 10.3389/fimmu.2023.1341314. eCollection 2023.
6
Stem Cell Therapy for the Management of Type 1 Diabetes: Advances and Perspectives.干细胞治疗 1 型糖尿病的管理:进展与展望。
Endocr Metab Immune Disord Drug Targets. 2024;24(5):549-561. doi: 10.2174/0118715303256582230919093535.
7
A Supportive Role of Mesenchymal Stem Cells on Insulin-Producing Langerhans Islets with a Specific Emphasis on The Secretome.间充质干细胞对胰岛素分泌性朗格汉斯胰岛的支持作用,特别强调分泌组
Biomedicines. 2023 Sep 18;11(9):2558. doi: 10.3390/biomedicines11092558.
8
Recent advances in pre-conditioned mesenchymal stem/stromal cell (MSCs) therapy in organ failure; a comprehensive review of preclinical studies.预处理间充质干细胞(MSCs)治疗器官衰竭的最新进展:临床前研究的综合综述。
Stem Cell Res Ther. 2023 Jun 7;14(1):155. doi: 10.1186/s13287-023-03374-9.
9
Mesenchymal Stem Cell in Pancreatic Islet Transplantation.间充质干细胞在胰岛移植中的应用
Biomedicines. 2023 May 11;11(5):1426. doi: 10.3390/biomedicines11051426.
10
Research Progress on Mesenchymal Stem Cells for the Treatment of Diabetes and Its Complications.间充质干细胞治疗糖尿病及其并发症的研究进展
Int J Endocrinol. 2023 Apr 24;2023:9324270. doi: 10.1155/2023/9324270. eCollection 2023.